NCT06257680View on ClinicalTrials.gov

A Phase I Study on ReT01 ACT for the Treatment of Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

February 18, 2025

Study Completion Date

February 18, 2027

Conditions
Advanced Solid Tumor
Interventions
BIOLOGICAL

ReT01 ACT

Patients were infused with ReT01 ACT injection after pretreatment, and subjects were closely observed for 24 hours after each infusion.

Trial Locations (1)

Unknown

RECRUITING

The Fifth Medical Center of Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Aeonvital Biomedicine

INDUSTRY